Advertisement

Non-ST-Segment Elevation Acute Coronary Syndromes (NSTE-ACS)

  • Justin Lee
  • Felix Reyes
  • Hanna Z. Mieszczanska
Chapter

Abstract

Despite advances in prevention, diagnosis, and treatment of coronary artery disease (CAD), non-ST segment elevation acute coronary syndromes (NSTE-ACS) remain a major cause of morbidity and mortality worldwide. There has been a significant decrease in mortality in the last several decades, which has been less prominent in women. However, the burden of recurrent ischemic events and mortality remains high (Eisen et al. JAMA Cardiology;1(6):718–30, 2016). It is important to understand how to distinguish NSTE-ACS from other forms of ACS, in order to initiate a proper management plan that directly correlates to the outcomes.

Keywords

Chest pain Angina Unstable angina Acute coronary syndrome Myocardial infarction 

References

  1. 1.
    Li Y-Q, Liu N, Lu J-H. Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: a meta-analysis. Clinics. 2014;69(6):398–404.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.CrossRefPubMedGoogle Scholar
  3. 3.
    Braunwald E. Unstable angina and non–ST elevation myocardial infarction. Am J Respir Crit Care Med. 2012;185(9):924–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Fanaroff AC, Rymer JA, Goldstein SA, Simel DL, Newby L. Does this patient with chest pain have acute coronary syndrome? The rational clinical examination systematic review. JAMA. 2015;314(18):1955–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016;1(6):718–30.CrossRefPubMedGoogle Scholar
  6. 6.
    Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–13.CrossRefPubMedGoogle Scholar
  7. 7.
    Havakuk O, Rezkalla SH, Kloner RA. The cardiovascular effects of cocaine. J Am Coll Cardiol. 2017;70(1):101–13.CrossRefPubMedGoogle Scholar
  8. 8.
    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMedGoogle Scholar
  9. 9.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–92.CrossRefPubMedGoogle Scholar
  10. 10.
    Pippel M, Allison BD, Phuong VK, Li L, Morton MF, Prendergast C, et al. Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series. Bioorg Med Chem Lett. 2009;19(22):6373–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Rodriguez F, Mahaffey KW. Management of patients with NSTE-ACS: a comparison of the recent AHA/ACC and ESC guidelines. J Am Coll Cardiol. 2016;68(3):313–21.CrossRefPubMedGoogle Scholar
  12. 12.
    Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–64.CrossRefPubMedGoogle Scholar
  13. 13.
    Wu AHB, Christenson R. The era for high-sensitivity cardiac troponin has begun in the US (finally). J Appl Lab Med. 2017;2(1):1–3.CrossRefGoogle Scholar
  14. 14.
    Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice. Heart. 2017;103(1):10–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol. 2014;63(23):2569–78.CrossRefPubMedGoogle Scholar
  16. 16.
    Antman EM, Cohen M, Bernink PM, et al. The timi risk score for unstable angina/non–ST elevation mi: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42.CrossRefPubMedGoogle Scholar
  17. 17.
    Fox KAA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK–Belgian Study). Eur Heart J. 2010;31(22):2755–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Gerschutz GP, Bhatt DL. The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevation. Cleve Clin J Med. 2002;69(5):377–8, 80, 82 passim.CrossRefPubMedGoogle Scholar
  19. 19.
    Bellemain-Appaix A, O’Connor SA, Silvain J, et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. JAMA. 2012;308(23):2507–16.CrossRefPubMedGoogle Scholar
  20. 20.
    Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57.CrossRefPubMedGoogle Scholar
  21. 21.
    Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372(19):1791–800.CrossRefPubMedGoogle Scholar
  22. 22.
    Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–15.CrossRefPubMedGoogle Scholar
  23. 23.
    Yeh RW, Secemsky EA, Kereiakes DJ, et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315(16):1735–49.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011;377(9784):2193–204.CrossRefPubMedGoogle Scholar
  25. 25.
    Valgimigli M, Frigoli E, Leonardi S, Rothenbühler M, Gagnor A, Calabrò P, et al. Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med. 2015;373(11):997–1009.CrossRefPubMedGoogle Scholar
  26. 26.
    Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non–ST-segment–elevation myocardial infarction. The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation. 2009;119(14):1873–82.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med. 2000;342(2):101–14.CrossRefPubMedGoogle Scholar
  28. 28.
    Hofmann R, James SK, Jernberg T, Lindahl B, Erlinge D, Witt N, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Dewilde WJM, Oirbans T, Verheugt FWA, Kelder JC, De Smet BJGL, Herrman J-P, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107–15.CrossRefPubMedGoogle Scholar
  30. 30.
    Melloni C, Washam JB, Jones WS, Halim SA, Hasselblad V, Mayer SB, et al. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy. Systematic review. Circ Cardiovasc Qual Outcomes. 2015;8(1):47–55.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Justin Lee
    • 1
  • Felix Reyes
    • 1
  • Hanna Z. Mieszczanska
    • 2
  1. 1.Department of MedicineState University of New York Downstate Medical CenterBrooklynUSA
  2. 2.University of Rochester Medical Center/CardiologyRochesterUSA

Personalised recommendations